Lymphangiogenesis in the bone-implant interface of orthopedic implants: Importance and consequence

Journal of Biomedical Materials Research - Part A

Volumn 77, Issue 1, 2006, Pages 119-127

  Jell, Gavin ^a   Kerjaschki, Dontscho ^b   Revell, Peter ^c   Al Saffar, Najat ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Angiogenesis; Bone regeneration; Inflammation; Joint replacement; Lymphatic vessels; Wear debris

Indexed keywords

BONE; CELLS; FLUIDS; MACROMOLECULES; ORTHOPEDICS; PATHOLOGY; PATIENT TREATMENT; PHYSIOLOGY; POLYETHYLENE GLYCOLS; PROSTHETICS; WEAR OF MATERIALS;

ANGIOGENESIS; BONE REGENERATION; INFLAMMATION; JOINT REPLACEMENT; LYMPHATIC CAPILLARY GROWTH; LYMPHATIC VESSELS; WEAR DEBRIS;

IMPLANTS (SURGICAL);

PODOPLANIN; VASCULOTROPIN RECEPTOR 3;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMPLANT; INTERSTITIAL FLUID; LYMPH VESSEL; LYMPHANGIOGENESIS; MALE;

AGED; AGED, 80 AND OVER; BONE AND BONES; FEMALE; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROSTHESES AND IMPLANTS; PROSTHESIS FAILURE; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 33645898952     PISSN: 00219304     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30548     Document Type: Article

References (51)

1. Hubble MJ, Smith EJ. Revision of failed total hip replacement. Br J Hosp Med 1996;55:432-436.
2. Revell PA, al Saffar N, Kobayashi A. Biological reaction to debris in relation to joint prostheses. Proc Inst Mech Eng [H] 1997;211:187-197.
3. Goldring SR, Schiller AL, Roelke M, Rourke CM, O'Neil DA, Harris WH. The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am 1983;65:575-584.
4. Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, Detmar M. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 2001;159:893-903.
5. Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, Kubista E, Hausmaninger H, Samonigg H, Gnant M, Jakesz R, Horvat R. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 2004;240:306-312.
6. Saaristo A, Karkkainen MJ, Alitalo K. Insights into the molecular pathogenesis and targeted treatment of lymphedema. Ann N Y Acad Sci 2002;979:94-110.
7. Wilkinson LS, Edwards JC. Demonstration of lymphatics in human synovial tissue. Rheumatol Int 1991;11:151-155.
8. Paavonen K, Mandelin J, Partanen T, Jussila L, Li TF, Ristimaki A, Alitalo K, Konttinen YT. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. J Rheumatol 2002;29:39-45.
9. Cliff S, Bedlow AJ, Stanton AW, Mortimer PS. An in vivo study of the microlymphatics in psoriasis using fluorescence microlymphography. Br J Dermatol 1999;140:61-66.
10. Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 2000;156:1499-1504.
11. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K, Kerjaschki D. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999;154:385-394.
12. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801.
13. Wigle JT, Oliver G. Proxl function is required for the development of the murine lymphatic system. Cell 1999;98:769-778.
14. Ebata N, Nodasaka Y, Sawa Y, Yamaoka Y, Makino S, Totsuka Y, Yoshida S. Desmoplakin as a specific marker of lymphatic vessels. Microvasc Res 2001;61:40-48.
15. Nibbs RJ, Kriehuber E, Ponath PD, Parent D, Qin S, Campbell JD, Henderson A, Kerjaschki D, Maurer D, Graham GJ, Rot A. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001;158:867-877.
16. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290-298.
17. Galland F, Karamysheva A, Pebusque MJ, Borg JP, Rottapel R, Dubreuil P, Rosnet O, Birnbaum D. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 1993;8:1233-1240.
18. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, Alitalo K. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 1996;122:3829-3837.
19. al Saffar N, Mah JT, Kadoya Y, Revell PA. Neovascularisation and the induction of cell adhesion molecules in response to degradation products from orthopaedic implants. Ann Rheum Dis 1995;54:201-208.
20. Jell GM, al Saffar N. Does a pro-angiogenic state exist in the bone-implant interface of aseptically loosened joint prosthesis? J Mater Sci Mater Med 2001;12:1069-1073.
21. Miyanishi K, Trindade MC, Ma T, Goodman SB, Schurman DJ, Smith RL. Periprosthetic osteolysis: Induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles. J Bone Miner Res 2003;18:1573-1583.
22. Cursiefen C, Schlotzer-Schrehardt U, Kuchle M, Sorokin L, Breiteneder-Geleff S, Alitalo K, Jackson D. Lymphatic vessels in vascularized human corneas: Immunohistochemical investigation using LYVE-I and podoplanin. Invest Ophthalmol Vis Sci 2002;43:2127-2135.
23. Case CP, Langkamer VG, James C, Palmer MR, Kemp AJ, Heap PF, Case CP, Solomon L. Widespread dissemination of metal debris from implants. J Bone Joint Surg Br 1994;76:701-712.
24. Urban RM, Jacobs JJ, Tomlinson MJ, Gavrilovic J, Black J, Peoc'h M. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J Bone Joint Surg Am 2000;82:457-476.
25. Hicks DG, Judkins AR, Sickel JZ, Rosier RN, Puzas JE, O'Keefe RJ. Granular histiocytosis of pelvic lymph nodes following total hip arthroplasty. The presence of wear debris, cytokine production, and immunologically activated macrophages. J Bone Joint Surg Am 1996;78:482-496.
26. Basle MF, Bertrand G, Guyetant S, Chappard D, Lesourd M. Migration of metal and polyethylene particles from articular prostheses may generate lymphadenopathy with histiocytosis. J Biomed Mater Res 1996;30:157-163.
27. Coleman MP. Cancer risk from orthopedic prostheses. Ann Clin Lab Sci 1996;26:139-146.
28. Peoc'h M, Ducros V, Barnoud R, Pasquier D, Laverriere MH, Pasquier B. Foreign body histiocytosis reaction after hip replacement with concomitant metastatic adenocarcinoma in the same lymph node. Hum Pathol 1998;29:95-98.
29. Arredondo J, Worland RL, Sinnenberg RJ Jr, Qureshi GD. Non-Hodgkin's lymphoma as an unexpected diagnosis in a shoulder arthroplasty. J Arthroplasty 1999;14:108-111.
30. Weyand CM, Geisler A, Brack A, Bolander ME, Goronzy JJ. Oligoclonal T-cell proliferation and interferon-gamma production in periprosthetic inflammation. Lab Invest 1998;78:677-685.
31. al Saffar N. Early clinical failure of total joint replacement in association with follicular proliferation of B-lymphocytes: A report of two cases. J Bone Joint Surg Am 2002;84A:2270-2273.
32. Podgrabinska S, Braun P, Velasco P, Kloos B, Pepper MS, Skobe M. Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci U S A 2002;99:16069-16074.
33. Jackson DG. The lymphatics revisited: New perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc Med 2003;13:1-7.
34. Walker RA. Ulex europeus I-peroxidase as a marker of vascular endothelium: Its application in routine histopathology. J Pathol 1985;146:123-127.
35. Hultberg BM, Svanholm H. Immunohistochemical differentiation between lymphangiographically verified lymphatic vessels and blood vessels. Virchows Arch A Pathol Anat Histopathol 1989;414:209-215.
36. Koizumi T, Shiraishi T, Hagihara N, Tabuchi K, Hayashi T, Kawano T. Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations. Neurosurgery 2002;50:117-124.
37. Ryan TJ. Microcirculation in psoriasis: Blood vessels, lymphatics and tissue fluid. Pharmacol Ther 1980;10:27-64.
38. Albuquerque M, de Lima JP. Articular lymphoscintigraphy in human knees using radiolabeled dextran. Lymphology 1990;23:215-218.
39. Karkkainen MJ, Alitalo K. Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis. Semin Cell Dev Biol 2002;13:9-18.
40. Skripitz R, Aspenberg P. Pressure-induced periprosthetic osteolysis: A rat model. J Orthop Res 2000;18:481-484.
41. Robertsson O, Wingstrand H, Kesteris U, Jonsson K, Onnerfalt R. Intracapsular pressure and loosening of hip prostheses. Preoperative measurements in 18 hips. Acta Orthop Scand 1997;68:231-234.
42. Beasley NJ, Prevo R, Banerji S, Leek RD, Moore J, van TP, Cox G, Harris AL, Jackson DG. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002;62:1315-1320.
43. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997;276(5317):1423-1425.
44. Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G, Pepper MS. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001;20:672-682.
45. Clarijs R, Schalkwijk L, Ruiter DJ, de Waal RM. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. Invest Ophthalmol Vis Sci 2001;42:1422-1428.
46. Salven P, Mustjoki S, Alitalo R, Alitalo K, Rafii S. VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 2003;101:168-172.
47. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002;161:947-956.
48. Kriehuber E, Breiteneder-Geleff S, Groeger M, Soleiman A, Schoppmann SF, Stingl G, et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med 2001;194:797-808.
49. Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V, Qi JH, Claesson-Welsh L, Alitalo K. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci U S A 1998;95:14389-14394.
50. Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 1999;86:2406-2412.
51. Kubo H, Cao R, Brakenhielm E, Makinen T, Cao Y, Alitalo K. Blockade of vascular endothelial growth factor receptor-3 signalling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci U S A 2002;99:8868-8873.